Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply health care professionals with a novel point-of-care diagnostic tool. Abionic therewith gives access to immediate results for various diseases, for example the fastest test for early sepsis detection.
